Bookmark

Add to MyYahoo RSS

Novartis News

News on Novartis (Ticker: NVS) continually updated from thousands of sources around the net.

Thursday | The Independent

Last leader of violent animal rights group jailed for six years

Debbie Vincent was part of group that falsely accused Huntingdon Life Sciences workers of being paedophiles, posted sanitary towels claimed to be infected with AIDS, and desecrated the grave of the mother of a pharmaceutical company director Note: We do not store your email address but your IP address will be logged to prevent abuse of this ... (more)

Comment?

Related Topix: Animal Rights, Prison, Activism, Biotech

Tue Apr 15, 2014

BioSpace

Novartis AG Ditches RNAi Development In Boston, Job Cuts Cited

Novartis isn't the only one hiring, others are hiring too! Check it out! Novartis is shuttering a large part of its once-ambitious RNAi research efforts in Boston, FierceBiotech has learned.

Comment?

Related Topix: Biotech

Cambridge Evening News

Stop Huntingdon Animal Cruelty (Shac) campaign against Huntingdon...

An animal rights protest group which aims to close down research firm Huntingdon Life Sciences was dubbed "quasi-terrorist" by an international pharmaceutical company seeking to protect staff against harassment.

Comment?

Related Topix: Animal Rights, Biotech

Mon Apr 14, 2014

Nucleic Acids Research

Computational modeling identifies key gene regulatory interactions...

Here, we have identified key candidate regulators of phenobarbital -mediated mouse liver tumorigenesis, a well-characterized model of non-genotoxic carcinogenesis, by applying a new computational modeling approach to a comprehensive collection of in vivo gene expression studies.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Pharmacology

Sun Apr 13, 2014

Seeking Alpha

China Biotech In Review: WuXi Receives Award For cGMP...

BVCF, a China private equity growth investor specializing in healthcare and life sciences, has closed its third fund, BVCF III, L.P, with capital of $188 million .

Comment?

Related Topix: Biotech, Healthcare Technologies, Healthcare Services Group, Medicine, Apparel, Healthcare Industry, Vitamin C, Supplement

Thu Apr 10, 2014

Vision Monday

Novartis appoints Jeff George as Division Head, Alcon as Kevin Buehler Retires

Novartis announced earlier this week the appointment of Jeff George as division head of Alcon , effective May 1, 2014.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Alcon, Biogen Idec

Wed Apr 09, 2014

Star-Telegram.com

Novartis names new division head at Alcon Labs in Fort Worth

Jeff George, who now heads the Novartis generic drugs division, Sandoz, which has its global headquarters in Holzkirchen, Germany, will succeed Kevin Buehler, who is retiring from Alcon, a eye pharmaceutical maker, after 30 years.

Comment?

Related Topix: Biotech, Alcon, Fort Worth, TX

BioResearch Online

Novartis And MNM Provide 2 Million Anti-Malarial Drugs In Zambia

Novartis announced that two million units of its pediatric anti-malarial drug have been shipped to Zambia as part of ongoing efforts to eradicate the disease under its collaboration with Malaria No More and its campaign Power of One.

Comment?

Related Topix: Biotech, Malaria, Medicine, Health

BioSpace

Seattle's Juno Therapeutics Pauses Trial After Patient Deaths

One of the most exciting new avenues in cancer research is the development of techniques to genetically re-engineer a patient's own immune cells to destroy tumors.

Comment?

Related Topix: Biotech, University of Pennsylvania, Memorial SloanKettering Cancer Center, Medicine, Hospital Administration, Healthcare Industry

Tue Apr 08, 2014

BioSpace

FDA Grants Breakthrough Status Designation To Novartis AG' Meningitis B Vaccine

Novartis NVS +0.01% AG in Basel announced early this morning that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation - a rapid development track - for potential approval of BexseroA , their innovative vaccine against type B meningococcal meningitis.

Comment?

Related Topix: Food and Drug Administration, Biotech, Noven Pharmaceuticals

Sun Apr 06, 2014

CSRwire.com

Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia

BASEL, SWITZERLAND , Apr. 07 /CSRwire/ - Novartis announced today that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More's Power of One campaign.

Comment?

Related Topix: Biotech, Novartis, Medicine, Malaria, Health, Healthcare Industry, Internet, Science / Technology

Thu Apr 03, 2014

Seeking Alpha

Novartis sues Biocon over patent

Accusing India drug maker Biocon of infringing on its diabetes drug Galvus patent, Novartis goes to Delhi's High Court in an attempt to stop the firm from launching a generic vildagliptin.

Comment?

Related Topix: Biotech

Wed Apr 02, 2014

AmericanBankingNews.com

Novartis Price Target Increased to $93.00 by Analysts at Leerink Swann

The firm currently has an "outperform" rating on the stock. Leerink Swann's price target suggests a potential upside of 10.05% from the company's current price.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Stanley

Tue Apr 01, 2014

Seeking Alpha

Novartis' Lead Ceritinib Could Capture Market Share From Pfizer

Novartis A.G. and worldwide collaborators published results of their Phase I clinical trial of the ALK inhibitor Ceritinib in the New England Journal of Medicine on March 27. Ceritinib is 20X more potent than Crizotinib, more selective, has a similar side-effect profile and offers a second chance when Crizotinib resistance develops.

Comment?

Related Topix: Biotech, Pfizer, Medicine, Healthcare Industry, Healthcare Law, Law, Health, Lung Cancer, Lymphoma, Genetics

Mon Mar 31, 2014

AmericanBankingNews.com

Novartis Sets New 1-Year High at $85.23

Novartis shares reached a new 52-week high during trading on Monday , AnalystRatings.NET reports.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, The Visionaire Group, Solve, Novartis AG, Eons

TheStreet.com

Why Novartis (NVS) Stock Is Higher Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Mozilla, TheStreet, Financial Markets

Investor's Business Daily

Stock Futures Look Favorable; Legg Mason, Novartis, Climb

Stock futures pointed firmly toward a positive open Monday, as the market prepared for the last trading day of March and the final session of the first quarter.

Comment?

Related Topix: Biotech

Thu Mar 27, 2014

Forbes.com

FDA And Meningitis B: Picking Winners And Losers

The recent death of a Drexel University student due to a rare meningitis B strain is an unquestionable tragedy; one that is made all the more tragic because two vaccines for this strain already exist .

Comment?

Related Topix: Drexel University, Vaccinations, Health, Princeton University, UC Santa Barbara, Biotech, Novartis, Medicine, Healthcare Industry

Seeking Alpha

Novartis lung-cancer drug produces response in over half of patients

Novartis' Ceritinib reduced the size of tumors in 58% of patients in a Phase I study of those suffering from a form of lung cancer that strikes 10,000 people a year in the U.S. Ceritinib is the leader of a class of drugs that targets a gene known as ALK and is 20 times as effective as a drug from Pfizer called Xalkori.

Comment?

Related Topix: Biotech, Health, Lung Cancer, Pfizer, Medicine, Healthcare Industry

Tue Mar 25, 2014

Forbes.com

VEA, RUSL: Big ETF Inflows

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Vanguard FTSE Developed Markets ETF , which added 8,499,999 units, or a 1.7% increase week over week.

Comment?

Related Topix: Biotech, Financial Markets

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••